OBJECTIVE: Different mechanical circulatory support (MCS) systems are used in children with intractable heart failure. However, the need for anticoagulation leads to hemorrhage with subsequent use of blood products. We compared the coagulation disorders and the need for blood products in children treated either with extracorporeal membrane oxygenation (ECMO) or with the Berlin Heart pulsatile pneumatic ventricular assist device. PATIENTS: We retrospectively reviewed the first 8-day course of 64 children who were on MCS for more than 2 days between 1990 and 2002. Thirty children (median age 7.4 years, weight 25.5 kg) received Berlin Heart support and 34 children (median age 1.8 years, weight 9.2 kg) ECMO. Anticoagulation was accomplished by continuous infusion of heparin. Red blood cell count, platelet count, aPTT, AT III, fibrinogen, and ACT were measured regularly. Depending on blood loss and the coagulation disorder, red blood cells, fresh frozen plasma, platelets, and AT III were substituted. RESULTS: There were no preoperative differences in hematological parameters between the two groups. In the Berlin Heart group platelet transfusion was 4.3 ml x kg x day vs 24.6 ml x kg x day in the ECMO group. Red blood cell substitution was 17.2 vs 60.3 ml.kg.day. Fresh frozen plasma substitution was 8.5 ml x kg x day vs 46.9 ml x kg x day (P<0.001). Even in the congenital heart defect subgroups, when MCS was implanted without recent cardiotomy, the differences were significant. Nevertheless, the mean daily values for hemoglobin, platelets, and fibrinogen were lower in the ECMO group. There was lower overall mortality in the Berlin Heart group. CONCLUSIONS: Compared to ECMO, use of the Berlin Heart in children results in less blood loss and lower consumption of red blood cells, platelets, and fresh frozen plasma.
OBJECTIVE: Different mechanical circulatory support (MCS) systems are used in children with intractable heart failure. However, the need for anticoagulation leads to hemorrhage with subsequent use of blood products. We compared the coagulation disorders and the need for blood products in children treated either with extracorporeal membrane oxygenation (ECMO) or with the Berlin Heart pulsatile pneumatic ventricular assist device. PATIENTS: We retrospectively reviewed the first 8-day course of 64 children who were on MCS for more than 2 days between 1990 and 2002. Thirty children (median age 7.4 years, weight 25.5 kg) received Berlin Heart support and 34 children (median age 1.8 years, weight 9.2 kg) ECMO. Anticoagulation was accomplished by continuous infusion of heparin. Red blood cell count, platelet count, aPTT, AT III, fibrinogen, and ACT were measured regularly. Depending on blood loss and the coagulation disorder, red blood cells, fresh frozen plasma, platelets, and AT III were substituted. RESULTS: There were no preoperative differences in hematological parameters between the two groups. In the Berlin Heart group platelet transfusion was 4.3 ml x kg x day vs 24.6 ml x kg x day in the ECMO group. Red blood cell substitution was 17.2 vs 60.3 ml.kg.day. Fresh frozen plasma substitution was 8.5 ml x kg x day vs 46.9 ml x kg x day (P<0.001). Even in the congenital heart defect subgroups, when MCS was implanted without recent cardiotomy, the differences were significant. Nevertheless, the mean daily values for hemoglobin, platelets, and fibrinogen were lower in the ECMO group. There was lower overall mortality in the Berlin Heart group. CONCLUSIONS: Compared to ECMO, use of the Berlin Heart in children results in less blood loss and lower consumption of red blood cells, platelets, and fresh frozen plasma.
Authors: Paul M Kirshbom; Nancy D Bridges; Richard J Myung; J William Gaynor; Bernard J Clark; Thomas L Spray Journal: J Thorac Cardiovasc Surg Date: 2002-01 Impact factor: 5.209
Authors: Jan J De Waele; Sebastiaan Van Cauwenberghe; Eric Hoste; Dominique Benoit; Francis Colardyn Journal: Intensive Care Med Date: 2003-01-16 Impact factor: 17.440
Authors: R Hetzer; M Loebe; E V Potapov; Y Weng; B Stiller; E Hennig; V Alexi-Meskishvili; P E Lange Journal: Ann Thorac Surg Date: 1998-11 Impact factor: 4.330
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: Marianne E Nellis; Arun Saini; Philip C Spinella; Peter J Davis; Marie E Steiner; Marisa Tucci; Melissa Cushing; Pierre Demaret; Simon J Stanworth; Stephane Leteurtre; Oliver Karam Journal: Pediatr Crit Care Med Date: 2020-03 Impact factor: 3.624
Authors: Jill M Cholette; Jennifer A Muszynski; Juan C Ibla; Sitaram Emani; Marie E Steiner; Adam M Vogel; Robert I Parker; Marianne E Nellis; Melania M Bembea Journal: Pediatr Crit Care Med Date: 2022-01-01 Impact factor: 3.971
Authors: Carlo R Bartoli; Steven C Koenig; Constantine Ionan; Kevin J Gillars; Mike E Mitchell; Erle H Austin; Laman A Gray; George M Pantalos Journal: Pediatr Crit Care Med Date: 2013-11 Impact factor: 3.624
Authors: Trisha E Wong; Yuan-Shung Huang; Jason Weiser; Thomas V Brogan; Samir S Shah; Char M Witmer Journal: J Pediatr Date: 2013-08-06 Impact factor: 4.406
Authors: Melania M Bembea; Ira M Cheifetz; James D Fortenberry; Timothy E Bunchman; Stacey L Valentine; Scot T Bateman; Marie E Steiner Journal: Pediatr Crit Care Med Date: 2018-09 Impact factor: 3.624
Authors: Karin Lukas; Karin Stadtherr; Andre Gessner; Daniel Wehner; Thomas Schmid; Hans Peter Wendel; Christof Schmid; Karla Lehle Journal: Materials (Basel) Date: 2017-03-24 Impact factor: 3.623